Mission Bio, the pioneer in high-throughput, targeted single-cell DNA and multi-omics analysis, announced data underscoring the ability of the Tapestri® Platform to potentially impact cancer therapy by correlating cell surface protein expression of potential therapeutic targets with multiple myeloma (MM) clonal populations. This breakthrough data demonstrates the potential for single-cell multi-omics to improve myeloma patient stratification and disease surveillance.
